Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker MXCT
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 10, 2026 | MXCT MaxCyte, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 10, 2026 | MXCT MaxCyte, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Nov 10, 2026 | MXCT MaxCyte, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 10, 2026 | MXCT MaxCyte, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 14, 2026 | MXCT MaxCyte, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 12, 2026 | MXCT MaxCyte, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 12, 2026 | MXCT MaxCyte, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 17, 2026 | MXCT MaxCyte, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 16, 2026 | MXCT MaxCyte, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| May 12, 2026 | MXCT MaxCyte, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 12, 2026 | MXCT MaxCyte, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 27, 2026 | MXCT MaxCyte, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Mar 24, 2026 | MXCT MaxCyte, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 24, 2026 | MXCT MaxCyte, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 20, 2026 | MXCT MaxCyte, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Jan 12, 2026 | MXCT MaxCyte, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 12, 2025 | MXCT MaxCyte, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 12, 2025 | MXCT MaxCyte, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 5, 2025 | MXCT MaxCyte, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 22, 2025 | MXCT MaxCyte, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 22, 2025 | MXCT MaxCyte, Inc. | 2.05 Costs Associated with Exit or Disposal Activities | 8-K | 8-K ↗ |
| Aug 11, 2025 | MXCT MaxCyte, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 6, 2025 | MXCT MaxCyte, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 6, 2025 | MXCT MaxCyte, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 25, 2025 | MXCT MaxCyte, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 18, 2025 | MXCT MaxCyte, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 18, 2025 | MXCT MaxCyte, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 7, 2025 | MXCT MaxCyte, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 7, 2025 | MXCT MaxCyte, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 11, 2025 | MXCT MaxCyte, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 11, 2025 | MXCT MaxCyte, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 30, 2025 | MXCT MaxCyte, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 13, 2025 | MXCT MaxCyte, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 27, 2024 | MXCT MaxCyte, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 27, 2024 | MXCT MaxCyte, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Dec 9, 2024 | MXCT MaxCyte, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 9, 2024 | MXCT MaxCyte, Inc. | 2.05 Costs Associated with Exit or Disposal Activities | 8-K | 8-K ↗ |
| Nov 6, 2024 | MXCT MaxCyte, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 6, 2024 | MXCT MaxCyte, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
39 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:52 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances